Skip to main content
. 2026 Feb 17;19(2):331. doi: 10.3390/ph19020331
5-FU 5-Fluorouracil
ATCC American Type Culture Collection
Ara-C Cytarabine
BRAF B-Raf proto-oncogene
BRCA1 Breast cancer gene 1
CO2 Carbon dioxide
Ct24 Control cell growth at 24 h
Ct72 Control cell growth at 72 h
DBS Docking binding score
DHFR Dihydrofolate reductase
DMAP 4-Dimethylaminopyridine
DMEM Dulbecco’s Modified Eagle Medium
DMSO Dimethyl sulfoxide
DNA Deoxyribonucleic acid
dTMP 2′-Deoxythymidine-5′-monophosphate
dTTP 2′-Deoxythymidine-5′-triphosphate
dUMP 2′-Deoxyuridine-5′-monophosphate
EDCI Ethyl-3-(3-dimethylaminopropyl)carbodiimide
EGF Epidermal growth factor
ELISA Enzyme-linked immunosorbent assay
EMEM Eagle’s Minimum Essential Medium
FACS Fluorescence-activated cell sorting
FBS Fetal bovine serum
FdUMP 5-Fluoro-2′-deoxyuridine-5′-monophosphate
FGFR Fibroblast growth factor receptor
FITC Fluorescein isothiocyanate
GI50 Concentration causing 50% growth inhibition
GEM Gemcitabine
HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
IC50 Half-maximal inhibitory concentration
KRAS Kirsten rat sarcoma viral oncogene homolog
LC-MS Liquid chromatography–mass spectrometry
MAPK Mitogen-activated protein kinase
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
MTX Methotrexate
NADPH Nicotinamide adenine dinucleotide phosphate (reduced form)
NGS Next-generation sequencing
NIS N-Iodosuccinimide
NMR Nuclear magnetic resonance
OD Optical density
PBS Phosphate-buffered saline
PDB Protein Data Bank
PI Propidium iodide
PI3K Phosphoinositide 3-kinase
PK Pharmacokinetics
RMSD Root mean square deviation
RNA Ribonucleic acid
RPMI Roswell Park Memorial Institute medium
SAR Structure–activity relationship
SG Sub-G1 phase
SDS-PAGE Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
SOCl2 Thionyl chloride
TGI Total growth inhibition
THF Tetrahydrofolate
TP53 Tumor protein p53
TS Thymidylate synthase
TYSY Thymidylate synthase (gene/protein notation)
wt Wild type